---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-003459"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2026-05-15T13:08:56+00:00"
generated_at: "2026-05-15T13:10:11.626252+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech CEO to receive 90% of salary as RSUs, up from 50%

## Summary
- CEO Pardeep Nijhawan will receive 90% of monthly base salary as fully vested RSUs, effective May 13, 2026.
- Previously, 50% of base salary was issued as RSUs; remaining 10% paid in cash for withholding and tax requirements.
- RSUs granted each month at month-end fair market value under the 2019 Equity Incentive Compensation Plan.

## SEC filing metadata
- accession: 0001171843-26-003459
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2026-05-15T13:08:56+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/0001171843-26-003459-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/f8k_051526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-003459
- JSON: https://secwatch.observer/filing/0001171843-26-003459.json
- Plain text: https://secwatch.observer/filing/0001171843-26-003459.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.